Our portfolio
Our clinical-stage therapeutic pipeline
UCLB has a robust pipeline of preclinical and clinical therapeutic assets originating from UCL. The schematic below illustrates the various stages of clinical development, including those in progress and those already marketed. Many of these assets have been partnered with commercial organisations, which are responsible for advancing them through clinical trials and ultimately bringing them to market for the benefit of patients.